For example, previous studies have demonstrated that ApoE4-target replacement (TR) mice express lower levels of total ApoE than ApoE3-TR mice, mainly through a reduction in ApoE4 levels, which was proposed to contribute to AD progression through impaired neuronal and synaptic homeostasis [34]. Here, APOE is linked to Alzheimer disease.